1 – 50 of 62
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
(
- Contribution to journal › Article
- 2022
-
Mark
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
(
- Contribution to journal › Letter
-
Mark
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
(
- Contribution to journal › Article
- 2021
-
Mark
Search for AL amyloidosis risk factors using Mendelian randomization
(
- Contribution to journal › Article
-
Mark
Germline variants at SOHLH2 influence multiple myeloma risk
(
- Contribution to journal › Article
- 2020
-
Mark
Genetic predisposition for multiple myeloma
(
- Contribution to journal › Scientific review
-
Mark
Second primary cancers in non-Hodgkin lymphoma : Family history and survival
(
- Contribution to journal › Article
-
Mark
Search for multiple myeloma risk factors using Mendelian randomization
(
- Contribution to journal › Article
-
Mark
Transcriptome-wide association study reveals candidate causal genes for lung cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
(
- Contribution to journal › Article
-
Mark
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia
(
- Contribution to journal › Article
-
Mark
Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients
(
- Contribution to journal › Letter
-
Mark
Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism
(
- Contribution to journal › Article
-
Mark
Genome-wide interaction and pathway-based identification of key regulators in multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS) : comparison with multiple myeloma
2019) In Leukemia(
- Contribution to journal › Letter
-
Mark
Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance
(
- Contribution to journal › Letter
-
Mark
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
(
- Contribution to journal › Article
- 2018
-
Mark
Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
(
- Contribution to journal › Letter
-
Mark
Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer : a nationwide, observational follow up study in Sweden
(
- Contribution to journal › Article
-
Mark
Second primary cancers in non-Hodgkin lymphoma : Bidirectional analyses suggesting role for immune dysfunction
(
- Contribution to journal › Article
-
Mark
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
(
- Contribution to journal › Article
-
Mark
Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population
(
- Contribution to journal › Article
- 2017
-
Mark
Risk of second cancer in Hodgkin lymphoma survivors and influence of family history
(
- Contribution to journal › Article
-
Mark
Genetic and regulatory mechanism of susceptibility to high-hyperdiploid acute lymphoblastic leukaemia at 10p21.2
(
- Contribution to journal › Article
-
Mark
Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts
(
- Contribution to journal › Letter
-
Mark
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
(
- Contribution to journal › Article
-
Mark
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
(
- Contribution to journal › Article
- 2016
-
Mark
Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
(
- Contribution to journal › Article
- 2015
-
Mark
Quantifying the heritability of testicular germ cell tumour using both population-based and genomic approaches.
(
- Contribution to journal › Article
-
Mark
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells
(
- Contribution to journal › Letter
-
Mark
The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
(
- Contribution to journal › Article
-
Mark
Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer.
(
- Contribution to journal › Article
-
Mark
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis
(
- Contribution to journal › Article
- 2014
-
Mark
Special section editorial.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
-
Mark
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.
(
- Contribution to journal › Article
-
Mark
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
(
- Contribution to journal › Article
- 2013
-
Mark
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
(
- Contribution to journal › Article
-
Mark
Genome-wide association study on differentiated thyroid cancer.
(
- Contribution to journal › Article
-
Mark
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma
(
- Contribution to journal › Article
-
Mark
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
(
- Contribution to journal › Article
-
Mark
The CCND1 c.870G > A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
(
- Contribution to journal › Article
-
Mark
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
(
- Contribution to journal › Article